Diabetes Care

Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The list provides an overview of European trade names with accompanying generic names. Trade and generic names may differ in other markets.

 
Insulin
   
Fiasp® Fast-acting insulin aspart Summary (SmPC)
Xultophy® Insulin degludec/liraglutide
(rDNA origin) injection
Summary (SmPC)
Ryzodeg® 70% insulin degludec and 30% insulin aspart (rDNA origin) injection Summary (SmPC)
Tresiba® Insulin degludec (rDNA origin) injection Summary (SmPC)
Levemir® Insulin detemir

Summary (SmPC)

NovoMix®

Biphasic insulin aspart

Summary (SmPC)

NovoRapid®

Insulin aspart

Summary (SmPC)

 

GLP1
   
Victoza® Liraglutide injection

Summary (SmPC)

 

OAD
   
NovoNorm®

Repaglinide

Summary (SmPC)

 

Human insulin
   
Mixtard®

Biphasic insulin

Summary (SmPC)

Actrapid®

Soluble insulin

Summary (SmPC)

Insulatard®

Isophane insulin

Summary (SmPC)

HQMMA/CD/0115/0022(1)a

Novo Nordisk Pro

Novo Nordisk Pro is the official Novo Nordisk online resource exclusively for healthcare professionals.

Go to Novo Nordisk Pro
 


Devices

Novo Nordisk offers a variety of insulin pens and needles to help people manage their diabetes. The insulin pens come in both prefilled and durable options.
Find out more at our Insulin pens and needles pages